(Q34379983)

English

Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4-aminosalicylic acid

1 reference

based on heuristic

inferred from title

author name string

Schreiber S

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Howaldt S

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Raedler A

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 August 1994

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1081-1085

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Inhibition of prostaglandin synthetase in human rectal mucosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

4-Aminosalicylic acid retention enemas in treatment of distal colitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

The role of the mucosal immune system in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

National Cooperative Crohn's Disease Study: results of drug treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375059

6 July 2018

Severe paraaminosalicylic acid hypersensitivity; blood and lymph node studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with topical administration of 4-aminosalicylic acid in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative Evaluation of Blood Levels and Tolerance of Sodium PAS nd Conjugated PAS and Ascorbic Acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled trial of ulcerative colitis with oral 4-aminosalicylic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7926910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.35.8.1081

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34379983&oldid=1568434247"